Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease
Academic Article
Publication Date:
2021
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
Keywords:
Aged; Antirheumatic Agents; Female; Humans; Immunoglobulin G4-Related Disease; Male; Middle Aged; Prognosis; Recurrence; Rituximab; T Follicular Helper Cells; Treatment Outcome
List of contributors:
Mancuso, G.; Jofra, T.; Lanzillotta, M.; Aiuti, A.; Cicalese, M. P.; di Colo, G.; Dagna, L.; Fousteri, G.; Della-Torre, E.
Published in: